Evidence map›Paper›PMID 38320222›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Association of Major Adverse Financial Events and Later-Stage Cancer Diagnosis in the United States.

Joan L Warren, Angela B Mariotto, Jennifer Stevens, Amy J Davidoff, Veena Shankaran, Kevin C Ward, Xiao-Cheng Wu, Stephen M Schwartz, Lynne Penberthy, K Robin Yabroff

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
5.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Joan L WarrenDivision of Cancer Control and Population Science, National Cancer Institute, Bethesda, MD.ORCID 0000-0002-6467-6769
Angela B MariottoDivision of Cancer Control and Population Science, National Cancer Institute, Bethesda, MD.ORCID 0000-0003-2423-1834
Jennifer StevensInformation Management Services, Calverton, MD.
Amy J DavidoffDivision of Cancer Control and Population Science, National Cancer Institute, Bethesda, MD.ORCID 0000-0001-8141-9249
Veena ShankaranFred Hutchinson Cancer Research Center, University of Washington, Seattle, WA.ORCID 0000-0001-8136-6140
Kevin C WardRollins School of Public Health, Emory University, Atlanta, GA.ORCID 0000-0001-5893-6192
Xiao-Cheng WuSchool of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA.ORCID 0000-0003-3663-5027
Stephen M SchwartzFred Hutchinson Cancer Research Center, University of Washington, Seattle, WA.ORCID 0000-0001-7499-8502
Lynne PenberthyDivision of Cancer Control and Population Science, National Cancer Institute, Bethesda, MD.
K Robin YabroffAmerican Cancer Society, Atlanta, GA.ORCID 0000-0003-0644-5572
National Cancer Institute · USUniversity of Washington · USAmerican Cancer Society · USEmory University · USInformation Management Services · USLouisiana State University Health Sciences Center New Orleans · US

Funding

NCI NIH HHS HHSN261201300016CNCI NIH HHS HHSN261201300016INCI NIH HHS HHSN261201800003C
6 · The paper itself

Abstract

purposeThis study assessed the prevalence of specific major adverse financial events (AFEs)-bankruptcies, liens, and evictions-before a cancer diagnosis and their association with later-stage cancer at diagnosis.

methodsPatients age 20-69 years diagnosed with cancer during 2014-2015 were identified from the Seattle, Louisiana, and Georgia SEER population-based cancer registries. Registry data were linked with LexisNexis consumer data to identify patients with a history of court-documented AFEs before cancer diagnosis. The association of AFEs and later-stage cancer diagnoses (stages III/IV) was assessed using separate sex-specific multivariable logistic regression.

resultsAmong 101,649 patients with cancer linked to LexisNexis data, 36,791 (36.2%) had a major AFE reported before diagnosis. The mean and median timing of the AFE closest to diagnosis were 93 and 77 months, respectively. AFEs were most common among non-Hispanic Black, unmarried, and low-income patients. Individuals with previous AFEs were more likely to be diagnosed with later-stage cancer than individuals with no AFE (males-odds ratio [OR], 1.09 [95% CI, 1.03 to 1.14];

conclusionOne third of newly diagnosed patients with cancer had a major AFE before their diagnosis. Patients with AFEs were more likely to have later-stage diagnosis, even accounting for traditional measures of socioeconomic status that influence the stage at diagnosis. The prevalence of prediagnosis AFEs underscores financial vulnerability of patients with cancer before their diagnosis, before any subsequent financial burden associated with cancer treatment.

Indexed as

Black or African AmericanNeoplasmsAdultAgedFemaleGeorgiaHumansMaleMiddle AgedRegistriesUnited StatesYoung Adult

Identifiers

PMID38320222
PMCPMC10950180
OpenAlexW4391558818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.